While the associations between AD biomarkers and CP volume/macrostructure did not reach statistical significance (Table 2), greater plasma pTau181 levels were significantly associated with greater T1 or T2, indicative of worse microstructural integrity. This evidence concerns the gene CP and Alzheimer disease.